UK biotech draws Pfiz­er back­ing in £40.5M Se­ries A for pep­tide-in­spired drugs

Curve Ther­a­peu­tics has raised £40.5 mil­lion ($51.4 mil­lion) in a Se­ries A round to ad­vance its small cyclic pep­tide-based dis­cov­ery plat­form and drug can­di­dates, in­clud­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER